Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-8,10-13 and 16-20 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
It is unclear what qualifies as an under-esterified PTA oligomer in claim 1. An oligomer from ethylene glycol and TPA in mole ratio of below 1:1? Below 2:1? Applicant’s arguments (page 10 of 12/23/25 arguments) indicate adding PTA (ie terephthalic acid) and ethylene glycol somehow qualifies as the “under-esterified” oligomer that is added. In fact, neither PTA nor ethylene glycol are oligomers. Neither are esters. This further renders the term “under-esterified PTA oligomer” indefinite.
Claim 2’s “n” lacks antecedent basis.
The following is a quotation of 35 U.S.C. 112(d):
(d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers.
The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph:
Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers.
Claim 17 rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements.
Claim Rejections - 35 USC § 102The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 1-4,6,8,11,12 and 171-4,6-8,11-13,17 and 19 rejected under 35 U.S.C. 102(a)(1) as being anticipated by Iwasyk 5811496.
Iwasyk’s comparison example 1 reacts a starting polymerizable “oligomer” with ethylene glycol in a pipeline reactor to form an oligomer of 5.04 repeating units (ie applicant’s Dp).
The starting polymerizable oligomer (col 9 line 5-16) is usually a mixture of BHET, oligomers of BHET and oligomers of mono(hydroxylethyl)terephthalate. The mono(hydroxylethyl)terephthalate and its oligomer presumably qualify as applicant’s “under-esterified PTA” as it contains some carboxyl groups.
While the BHET isn’t said to be recycled BHET, virgin BHET and recycled BHET are exactly the same. Applicant’s claims do not require a “recycling” step to obtain the rBHET. Instead the recycled BHET is a product by process type limitation.
The amount of carboxyl endgroups is 419eq/106g or 419 mol/metric tonne.
Applicant relates molecular weight (Mn) to Dp by the formula Dp=(Mn-62)/192 (paragraph 33 of spec). This means Iwasyk’s Mn is 1030g/mol. Given the oligomer has two end groups, the total number of endgroups (-OH + -COOH) would be:
2 total endgroups/mol olig
-------------------------------------- = 0.00194 total endgroups/g = 1940 total endgrps/ton
1030g/mol olig
The amount of acid groups is therefore 1940-419 = 1521mol/ton.
The ratio of hydroxyl grps/carboxyl grps is 1521/419 = 3.6
In regards to applicant’s dependent claims:
The reaction temperature of the cited example is 2800C – meeting applicant’s claim 6.
The reaction pressure of the cited example is 222psig (ie 15.3 barg) – meeting applicant’s claim 8.
Antimony glycolate is used as catalyst in the cited example – meeting applicant’s claims 11 and 12.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claim 7 rejected under 35 U.S.C. 103 as being unpatentable over Iwasyk 5811496.
Iwask applies as explained above.
The cited example does not report the polymerization time.
However, Iwasyk (col 10 line 8) teaches 1-60 minutes and would have been obvious.
Claim 13 rejected under 35 U.S.C. 103 as being unpatentable over Iwasyk 5811496.
Iwask applies as explained above.
The cited example does not send the resultant oligomer to a final PET manufacturing process.
However, Iwasyk (col 9 line 26-30) teaches this is the ultimate purpose of the oligomers.
Using example 1’s oligomer in a PET production process would have been obvious.
Claim 19 rejected under 35 U.S.C. 103 as being unpatentable over Iwasyk 5811496.
Iwask applies as explained above.
The cited example’s temperature is slightly above the claim’s 2700C maximum.
However, Iwasyk more broadly suggests 2600C (col 9 line 43).
Lowering the cited example’s polymerization temperature would have been obvious to one of ordinary skill.
Claims 1-4,6-8,11-13,17 and 19 rejected under 35 U.S.C. 103 as being unpatentable over Iwasyk 5811496.
Iwasyk applies as explained above.
Iwasyk does not state the cited example’s oligomer has both BHET and oligomers of mono(hydroxylethyl)terephthalate with 100% certainty. Iwasyk (col 9 line 11) uses the phrase “usually yields a mixture of”. If not considered anticipatory, this teaching renders obvious the use of both in the reaction.
Applicant's arguments filed 4/3/26 have been fully considered but they are not persuasive.
Applicant argues “under-esterified PTA oligomer” would be understood by one of ordinary skill in view of paragraph 68 of the specification.
A search for “underesterified”, “under-esterfied” and “under esterified” in the US Patent data base reveals only seven documents (one of which is the instant application’s publication). None are directed to oligomers (except for the instant application).
Paragraph 68 of the specification does not clarify the meaning. There, “running at lower T, lower EG:TA, lower inventory etc” is taught. However, lower than what numerical value is never stated.
One might guess the oligomer must have some amount of carboxylic acid endgroups, but paragraph 68 casts doubt on that interpretation. If the oligomer below can be made at 2500C, will the same oligomer be considered “underesterified” if made at 2250C despite having no carboxylic acid end groups? Even more confusing is the “lower inventory” teaching. If the oligomer below can be made continuously at a rate of 1000kg/hr, will changing to a rate of 750kg/hr qualify this same oligomer as “underesterified” despite having no carboxylic acid endgroups?
PNG
media_image1.png
147
359
media_image1.png
Greyscale
Any inquiry concerning this communication or earlier communications from the examiner should be directed to DAVID J BUTTNER whose telephone number is (571)272-1084. The examiner can normally be reached M-F 9-3pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/DAVID J BUTTNER/Primary Examiner, Art Unit 1765 7/17/26